Female sexual response implies a deep intertwining between psychosocial and neurobiological mediators. Regulation of central melanocortin signaling may enhance sexual desire. In premenopausal women with hypoactive sexual desire disorder (HSDD), melanocortin receptor agonist bremelanotide (Vyleesi) has been hypothesized to trigger excitatory brain pathways.

An evaluation of bremelanotide injection for the treatment of hypoactive sexual desire disorder / Cipriani, Sarah; Alfaroli, Chiara; Maseroli, Elisa; Vignozzi, Linda. - In: EXPERT OPINION ON PHARMACOTHERAPY. - ISSN 1744-7666. - STAMPA. - 24:(2023), pp. 15-21. [10.1080/14656566.2022.2132144]

An evaluation of bremelanotide injection for the treatment of hypoactive sexual desire disorder

Cipriani, Sarah;Alfaroli, Chiara;Maseroli, Elisa;Vignozzi, Linda
2023

Abstract

Female sexual response implies a deep intertwining between psychosocial and neurobiological mediators. Regulation of central melanocortin signaling may enhance sexual desire. In premenopausal women with hypoactive sexual desire disorder (HSDD), melanocortin receptor agonist bremelanotide (Vyleesi) has been hypothesized to trigger excitatory brain pathways.
2023
24
15
21
Cipriani, Sarah; Alfaroli, Chiara; Maseroli, Elisa; Vignozzi, Linda
1a - Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1286652
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 1
social impact